709 related articles for article (PubMed ID: 32929378)
1. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.
Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Kovanen PT; Hadzijusufovic E; Sadovnik I; Horny HP; Arock M; Schwartz LB; Austen KF; Metcalfe DD; Galli SJ
Theranostics; 2020; 10(23):10743-10768. PubMed ID: 32929378
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
Valent P; Horny HP; Triggiani M; Arock M
Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
[TBL] [Abstract][Full Text] [Related]
3. Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis.
Renke J; Kędzierska-Mieszkowska S; Lange M; Nedoszytko B; Wasilewska E; Liberek A; Renke M; Niedoszytko M; Witkowski J; Skórko-Glonek J; Lipińska B
Adv Med Sci; 2019 Mar; 64(1):124-130. PubMed ID: 30641273
[TBL] [Abstract][Full Text] [Related]
4. Our perception of the mast cell from Paul Ehrlich to now.
Beaven MA
Eur J Immunol; 2009 Jan; 39(1):11-25. PubMed ID: 19130582
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
[TBL] [Abstract][Full Text] [Related]
6. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
7. Mast Cells as Drivers of Disease and Therapeutic Targets.
Siebenhaar F; Redegeld FA; Bischoff SC; Gibbs BF; Maurer M
Trends Immunol; 2018 Feb; 39(2):151-162. PubMed ID: 29196147
[TBL] [Abstract][Full Text] [Related]
8. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
9. Targeting c-kit in the therapy of mast cell disorders: current update.
El-Agamy DS
Eur J Pharmacol; 2012 Sep; 690(1-3):1-3. PubMed ID: 22789565
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment options for mast cell activation disease.
Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
[TBL] [Abstract][Full Text] [Related]
11. Mast Cells as Key Players in Allergy and Inflammation.
González-de-Olano D; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2018 Dec; 28(6):365-378. PubMed ID: 30530385
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Ingestion Inhibits Mastocytosis and Suppresses Intestinal Anaphylaxis in a Murine Model of Food Allergy.
Kinney SR; Carlson L; Ser-Dolansky J; Thompson C; Shah S; Gambrah A; Xing W; Schneider SS; Mathias CB
PLoS One; 2015; 10(7):e0132467. PubMed ID: 26147007
[TBL] [Abstract][Full Text] [Related]
13. IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure.
Babina M; Guhl S; Artuc M; Zuberbier T
Arch Dermatol Res; 2016 Nov; 308(9):665-670. PubMed ID: 27650274
[TBL] [Abstract][Full Text] [Related]
14. The development of human mast cells. An historical reappraisal.
Ribatti D
Exp Cell Res; 2016 Mar; 342(2):210-5. PubMed ID: 26997528
[TBL] [Abstract][Full Text] [Related]
15. Mast cell ontogeny: an historical overview.
Ribatti D; Crivellato E
Immunol Lett; 2014; 159(1-2):11-4. PubMed ID: 24534641
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature.
Kocabas CN; Yavuz AS; Lipsky PE; Metcalfe DD; Akin C
J Allergy Clin Immunol; 2005 Jun; 115(6):1155-61. PubMed ID: 15940128
[TBL] [Abstract][Full Text] [Related]
17. Controlling Mast Cell Activation and Homeostasis: Work Influenced by Bill Paul That Continues Today.
Caslin HL; Kiwanuka KN; Haque TT; Taruselli MT; MacKnight HP; Paranjape A; Ryan JJ
Front Immunol; 2018; 9():868. PubMed ID: 29755466
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
[TBL] [Abstract][Full Text] [Related]
19. Mast cell disorders: A framework of allergy and hematology symptoms leading to personalized treatments.
Castells MC
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):403-404. PubMed ID: 34593102
[No Abstract] [Full Text] [Related]
20. New insight into systemic mastocytosis mediated by cytokines IL-1β and IL-33: Potential inhibitory effect of IL-37.
Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Pandolfi F
Eur J Pharmacol; 2019 Sep; 858():172473. PubMed ID: 31228452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
